Ledger.Open graph →
SEC Form D · filed March 10, 2017

Neurana Pharmaceuticals, Inc

Offering
$3.5M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Judy Caron · San Diego, CAExecKathleen D. Scott · San Diego, CAExecBrian F. Dorsey · San Diego, CADirectorDavid F. Hale · San Diego, CADirectorThomas D. Stevens · Los Angeles, CAExecDaniel E. Allen · Los Angeles, CADirectorColin Campbell · Clinton, WADirectorHal W. Reynolds · Los Angeles, CAExecJeffrey Raser · San Diego, CAExec · DirectorPaul Touchstone · SAN FRANCISCO, CADirectorTim Mcdowell · San Francisco, CAExecGabriel M. Paez · Portland, ORExecHugh M. Mackworth · Portland, ORDirectorJeffrey Raser · San Diego, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗